AI assistant
Unite Group PLC — Director's Dealing 2019
Nov 1, 2019
4793_dirs_2019-11-01_9758eace-05c4-49ca-82c5-5750e7577cb3.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0339S
Unite Group PLC
01 November 2019
THE UNITE GROUP PLC (THE "COMPANY")
1 November 2019
DIRECTOR PARTICIPATION IN SCRIP DIVIDEND SCHEME
The Company announces the following PDMR dealing in accordance with Article 19 of the Market Abuse Regulation:
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Elizabeth McMeikan
2
Reason for the notification
a)
Position/status
Non-Executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
The Unite Group plc
b)
LEI
213800BBUUWVDH9YI827
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 25p each
GB0006928617
b)
Nature of the transaction
Election under Scrip Dividend Scheme for 2019 interim dividend
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| 1067.60 pence per share | 44 shares |
d)
Aggregated information
- Aggregated volume
- Price
44 shares
Scrip Reference Share Price : 1067.60 pence per share
e)
Date of the transaction
1 November 2019
f)
Place of the transaction
London Stock Exchange
For further information, please contact:
| Unite Students Christopher Szpojnarowicz, Company Secretary |
Tel: +44 117 302 7120 |
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHUASSRKRAARAA